Alessa Therapeutics Announces First Patient Enrollment in Biolen®+RT Study with National Cancer Institute
Alessa Therapeutics Announces IND Clearance for a Study in Collaboration with the National Cancer Institute
Alessa Therapeutics Announces First Australian Patient Enrolled in Biolen-PC Study for Localized Drug Delivery for Prostate Cancer
Alessa Therapeutics Announces First Patient Enrolled in Biolen-PC Study for Localized Drug Delivery for Prostate Cancer